Deltex Medical sees blood flow monitor sales double

Deltex Medical, the makers of a device which monitors blood flow during and after operations, says it is beginning to benefit from an official recommendation by the National Institute for Health and Clinical Excellence (NICE).

In March last year NICE recommended that the CardioQ-ODM system be considered for use in all patients undergoing major and high risk surgery in the NHS. Since December Deltex has seen a 40% increase in sales of its surgical probes compared to the prior year.

The firm still awaits the adoption of ODM as one of six "high impact" technologies to be implemented in the NHS but is pinning its hopes on a report to be published this Summer which may give the official stamp of approval.

Article continues below

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

By 11:30 the stock had risen 2.7%.

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.